7:00AM – 7:45AM COFFEE/NETWORKING 

7:45AM – 8:15AM WELCOME & CE OVERVIEW 

---

8:15AM – 9:45AM | GENERAL SESSION-ENDING THE OPIOID CRISIS
Christi Jen, PharmD, BCPS, BCEMP, FASHP, FAzPA; Holly Geyer, MD 

 

Pharmacist Learning Objectives: 

1. Identify the role of overprescribing in opioid-related complications.
2. Analyze the difference between opioid misuse and addiction. 
3. Identify opioid use disorder. 
4. Describe safe opioid prescribing recommendations. 
5. Describe safe opioid administration recommendations.  

Technician Learning Objectives: 

1. Identify the role of overprescribing in opioid-related complications. 
2. Analyze the difference between opioid misuse and addiction. 
3. Identify opioid use disorder. 

ACPE UAN: 0100-0000-23-182-L08-P/T

---

10:00AM - 11:00AM | Updates in Geriatric Medicine: A Musical Journey
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA; Jacob Lahti, BS; CMD; Pranav Pillai, MBBS; Samantha Russell, MD; Walter Nieri, MD 

Pharmacist Learning Objectives: 

1. Describe how to determine if a paper adds to the evidence base. 
2. Discuss three recent papers in the geriatric literature.

ACPE UAN: 0100-9999-23-169-L01-P

 

10:00AM - 11:00AM | Thanks for the Feedback - Frequent, Immediate, Specific, and Constructive Feedback for Pharmacy Residents
Kelly Erdos, PharmD, BCACP, CACP; Michaela Konecnik, PharmD, BCPS; Daniel Bell, PharmD, BA, BCPS 

Pharmacist Learning Objectives: 

1. Describe the four elements needed to provide effective feedback to residents. 
2. Interpret feedback from residents and resident evaluations to determine how to improve feedback to residents. 
3. Discuss the importance of implementing a preceptor development program. 

ACPE UAN: 0100-0000-23-183-L99-P

---

11:15AM - 12:15AM | Managing Chronic Disease in Frail Older Adults in the Outpatient Setting
Rosemary Browne, MD, FACP, AGSF

Pharmacist Learning Objectives: 

1. Describe Age Friendly Health Systems. 
2. Discuss prognostication as a tool to help prioritize medical decision making. 
3. Explain the concepts of multi-complexity and multi-morbidity. 
4. Describe patient priorities care.

Technician Learning Objectives: 

1. Describe Age Friendly Health Systems. 
2. Describe patient priorities care. 

ACPE UAN: 0100-9999-23-166-L01-P/T

 

11:15AM - 12:15AM | Focus on Anticoagulation: Anticoagulation Reversal: When the Clock is Ticking
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA; John Robinson, PharmD, BCCCP 

Pharmacist Learning Objectives: 

1. Distinguish between approved anticoagulation reversal agents specific to oral anticoagulants. 
2. Identify reversal agents currently in development. 
3. Design a treatment plan on the presentation of a patient in need of emergent reversal of their anticoagulation. 

ACPE UAN: 0100-0000-23-184-L01-P

---

12:30PM - 1:15PM | NON ACCREDITED-SYMPOSIUM

Jeannie Grubbs, PharmD

Epidemiologic Trends in Adult Invasive Pneumococcal Disease and Unmet Needs

Sponsored by Merck

---

1:30PM - 2:30PM | Elevating Pharmacy Practice: Managing Up for Pharmacy Professionals
Kimberly Langley, PharmD, MBA, BCPS, CPBPM 

Pharmacist & Technician Learning Objectives: 

1. Explain the concept of managing up for effective employee-employer relationships.  
2. Review strategies for effective employee-employer relationship through managing up.  
3. Describe strategies for facilitating communication with your supervisory leadership. 
4. Discuss guidance for improvement when the employee-employer relationship becomes challenging. 

ACPE UAN: 0100-0000-23-185-L04-P/T 

 

1:30PM - 2:30PM | Focus on Anticoagulation: The Reversal Rumble: Anticoagulation Clinical Debate
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA; John Robinson, PharmD, BCCCP 

Pharmacist Learning Objectives: 

1. Critique the evidence for using fixed-dose 4F-PCC in the reversal of anticoagulation in patients receiving warfarin. 
2. Evaluate the evidence of 4F-PCC and andexanet alfa in the reversal of rivaroxaban and apixaban.

ACPE UAN: 0100-0000-23-186-L01-P

---

2:45PM - 3:45PM | Focus on Anticoagulation: Stay in the KNOWac about the DOACs: A Pediatric Perspective
Lauren Campisi, PharmD; Tran Nguyen, PharmD, BCPPS, BS

Pharmacist Learning Objectives: 

1. Describe the common indications for use of the DOACs in pediatric patients. 
2. Interpret the current literature for use of the DOACs in pediatric patients. 
3. Compare the differences between use of DOACs in pediatric and adult populations. 

ACPE UAN: 0100-0000-23-173-L01-P

 

2:45PM - 3:45PM | Creating a Culture of Positive Feedback and Recognition for Pharmacy Technicians
Kristine Smith, B.S., CPhT-Adv, CSPT; Nick Ruiz, CPhT-Adv, CSPT, FAPC; Matthew Alvarado; Matthew Alvarado, CPhT, CSPT

Pharmacist & Technician Learning Objectives: 

1. List various feedback models. 
2. Describe how to effectively give feedback. 
3. Explain how feedback directly impacts engagement.

ACPE UAN: 0100-0000-23-187-L04-P/T

---

4:00PM - 5:00PM | General Session - National Pharmacy Policy Update and Workforce Priorities
Anna Dopp, PharmD, CPHQ-Senior Director, Government Relations at ASHP

Pharmacist & Technician Learning Objectives:

1. List national policy priorities for the pharmacy profession.
2. List national advocacy efforts for the pharmacy profession.
3. Describe current state regulatory and legislative issues impacting the pharmacy workforce.
4. Describe current federal regulatory and legislative issues impacting the pharmacy workforce.
5. Identify resources available to support practice advancements and advocacy efforts.

ACPE UAN: Pending

7:00AM – 7:45AM COFFEE/NETWORKING 

7:45AM – 8:15AM WELCOME & CE OVERVIEW 

---

8:15AM – 9:45 AM | GENERAL SESSION -PHARMACY LAW UPDATE
Roger Morris, RPh, JD; Catherine Lavinge, JD; Bailey Walden, JD

Pharmacist & Technician Learning Objectives: 

1. Describe ramifications of recent pharmacy-related court cases.  
2. List recent changes in Federal Pharmacy Law. 

ACPE UAN: 0100-0000-23-188-L03-P/T

---

10:00AM -11:00AM | Let Your Voice Be Heard:  A Discussion of Advocacy and ASHP House of Delegates 
Janelle Duran, PharmD, BCPS; Chris Edwards, PharmD, BCPS, FASHP; Christi Jen, PharmD, BCPS, BCEMP, FASHP, FAzPA; Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA; Melinda Burnworth, PharmD, FASHP, FAzPA, BCPS

Pharmacist Learning Objectives: 

1. Describe ways Arizona pharmacy professionals can get involved in advocacy through state and national pharmacy associations. 
2. Discuss the role of Arizona delegates to the ASHP House of Delegates. 
3. Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and to pharmacy personnel.

Technician Learning Objectives: 

1. Describe how a pharmacy technician may contribute to ASHP policies.
2. Recognize how policies may impact pharmacy technicians.

ACPE UAN: 0100-0000-23-189-L99-P/T

 

10:00AM -11:00AM | Our Journey to Becoming PALS
Brandy DeChellis, PharmD; Mikayla Gerdes, PharmD Candidate; Bradley Nash, BS Biochemistry, PharmD

Pharmacist Learning Objectives: 

1. Discuss how to recognize life-threatening emergencies such as cardiac arrest in pediatric patients.  
2. Describe Pediatric Advanced Life Support (PALS) Certification.
3. List the resources available for PALS training.  
4. List common medications used during a pediatric code. 
5. Describe the role of the pharmacist attending a code within a high-performance team. 

Technician Learning Objectives: 

1. Discuss how to recognize life-threatening emergencies such as cardiac arrest in pediatric patients.  
2. Describe Online Pediatric Advanced Life Support (PALS) Certification. 
3. List the resources available for PALS training.  
4. List common medications used during a pediatric code. 

ACPE UAN: 0100-0000-23-190-L04-P/T 

---

11:30AM–1:00PM | JOURNAL CLUB: PHASE 2 TRIAL OF LENACAPAVIR IN NEW START TREATMENT OF HIV; PHARMACIST ADMINISTRATION OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS TO COMMUNITY-DWELLING PATIENTS; OPTIMIZING OPIOID USE DISORDER TREATMENT WITH NALTREXONE OR BUPRENORPHINE; FINAL NAIL FOR PHENYLEPHRINE

Jeffrey Bezard, PharmD; Monica Heberling, PharmD; Jkiya Jackson, PharmD; Michael Constant, PharmD; Victor Camargo, PharmD; Daniel Otis, PharmD; Kimberly Johnson, PharmD

Pharmacist Learning Objectives: 

1. Discuss the results compiled in the phase 2 study of lenacapavir for use in new start HIV treatment.
2. Describe potential treatment regimens utilizing lenacapavir.
3. List current available long-acting injectable formulations of antipsychotics.
4. Discuss drawbacks of utilizing long-acting injectable versions of antipsychotic medications
5. List challenges in the treatment of Opioid Use Disorder (OUD) with buprenorphine and naltrexone.
6. Describe evidence-based practices to determine an individualized treatment plan for patients diagnosed with OUD.
7. Describe the results of the Nonprescription Drugs Advisory Committee on Phenylephrine.
8. Describe the efficacy of phenylephrine as described in the study

ACPE UAN: 0100-0000-23-192-L01-P/T 

 

11:30AM–1:00PM | New Drug Update
Christina Meridew, PharmD Candidate; Courtney Cianci, PharmD Candidate; Jasmina Hukic, PharmD Candidate;  Joseph Zeppa, PharmD Candidate; Lyndy Abdelsayed, PharmD Candidate; Monique Cazares, PharmD Candidate; Mikayla Gerdes, PharmD Candidate; Dawn Gerber, PharmD, BCGP, FASCP, AzPA 

Pharmacist Learning Objectives: 

1. Describe pharmacological mechanisms of action of newly available medications. 
2. Describe the clinical efficacy of newly available medications. 
3. Describe the adverse effect profile of newly available medications. 
4. Identify patient counseling points for newly available drugs.
    

Technician Learning Objectives: 

1. Describe pharmacological mechanisms of action of newly available medications. 
2. Describe the storage requirements of newly available medications. 
3. List the indications of newly available medications. 

ACPE UAN: 0100-0000-23-191-L01-P/T